EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Treatment-Associated Differences in Serum Cytokine Profiles in Canine Atopic Dermatitis: A Cross-Sectional Study

Jae-Yun Ko, Min-Hee Kang, Kwang-Sup Lee iD, Hee-Myung Park

Animals · 03.08.2026 · 16 (15) · 2390

DOI: 10.3390/ani16152390 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Animals, online erschienen am 03.08.2026. Verfasst von Jae-Yun Ko und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pyeonanhan Animal Hospital, Daejeon 34069, Republic of Korea. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic immunomodulatory treatments are widely used in canine atopic dermatitis (cAD), but treatment-associated differences in circulating cytokine profiles remain unclear. This cross-sectional study compared serum cytokine concentrations in 143 dogs: Healthy (n = 28), Untreated AD (n = 27), Prednisolone (n = 23), Oclacitinib (n = 29), Lokivetmab (n = 19), and Cyclosporine (n = 17). Serum concentrations of IFN-γ, IL-10, IL-13, IL-31, and TGF-β1 were quantified using enzyme-linked immunosorbent assays. pVAS and CADESI-04 were compared among the five cAD groups. All five cytokines differed significantly among the six groups. The Prednisolone group had lower pVAS scores than the Untreated AD group (p = 0.002) and the Cyclosporine group (p = 0.001), despite having the highest median serum IL-31 concentration (163.9 pg/mL), which was significantly higher than that in each of the other groups (p ≤ 0.003). The Prednisolone group showed lower IL-13 concentrations than the Healthy and Untreated AD groups (both p = 0.001). IFN-γ concentrations were lower in the Oclacitinib, Lokivetmab, and Cyclosporine groups than in the Healthy group (p ≤ 0.002). Serum cytokine profiles differed among groups defined by treatment status; however, these cross-sectional differences cannot be interpreted as direct treatment effects. The discordance between pVAS and serum IL-31 in the Prednisolone group indicates that circulating cytokine concentrations may not consistently parallel concurrent clinical severity and should be interpreted as a hypothesis-generating observation rather than an established biological relationship. Longitudinal studies are needed to clarify whether these profiles reflect treatment exposure, underlying disease heterogeneity, or both.

Schlagwörter

Stichwörter der Autor:innen

CADESI-04IL-31canine atopic dermatitispruritusserum cytokinessystemic immunomodulators

Autor:innen und Institutionen

  • Pyeonanhan Animal Hospital, Daejeon 34069, Republic of Korea.
  • Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea.
  • Department of Bio-Animal Health, Jangan University, Hwaseong 18331, Republic of Korea.
  • Gyeonggi Animal Medical Center, Yongin 17023, Republic of Korea.

ORCID-Profile: Kwang-Sup Lee

Zitieren

APA

Ko, J. Y., Kang, M. H., Lee, K. S., & Park, H. M. (2026). Treatment-Associated Differences in Serum Cytokine Profiles in Canine Atopic Dermatitis: A Cross-Sectional Study. Animals, 16(15), 2390. https://doi.org/10.3390/ani16152390

Vancouver

Ko JY, Kang MH, Lee KS, Park HM. Treatment-Associated Differences in Serum Cytokine Profiles in Canine Atopic Dermatitis: A Cross-Sectional Study. Animals. 2026;16(15):2390. doi:10.3390/ani16152390

BibTeX
@article{Ko2026,
  author = {Ko, Jae-Yun and Kang, Min-Hee and Lee, Kwang-Sup and Park, Hee-Myung},
  title = {Treatment-Associated Differences in Serum Cytokine Profiles in Canine Atopic Dermatitis: A Cross-Sectional Study},
  journal = {Animals},
  year = {2026},
  volume = {16},
  number = {15},
  pages = {2390},
  doi = {10.3390/ani16152390}
}
Kostenlos starten →